I bought NEPT and ACB and sold both at a loss. I’m just gonna buy MJ and be done with it
Down but about to rebound? Only stock picks
- Thread starter morris
- Start date
Are there any penny stock marijuana pics that may blow up? I don't deal with pink sheets/OTC stocks by the wayI bought NEPT and ACB and sold both at a loss. I’m just gonna buy MJ and be done with it
KGKG
HIPH
NOUV
KALY
PURA
USMJ
I believe all of these are OTC. KGKG did well for me when I owned it but I sold my position because I found that penny stocks weren’t for me
These stocks are gonna be long holds waiting out the legal situation for weed to change federally in the United States. If the next president is a democrat it could happen. Many states have already legalized it anyway. It seems almost inevitable that weed will become legal in the US inside the next 8 years.I bought NEPT and ACB and sold both at a loss. I’m just gonna buy MJ and be done with it
Tug life
I stay fly like a guillemot
You guys need to check out this bio pharm stock Cormedix CRMD I bought shares of this at an average of .61 cents in October and its now at $1.70. They have a product called Neutrolin which is already successful in Europe and is seeking FDA approval in the states. Institutions are buying this up such as Blackrock, and Vanguard group as well as insiders. This stock has been my best performing over the last 3 months. This is an extremely strong buy for me and im going all in on this.
Brief:CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced the topline results of the interim analysis of the Company's Phase 3 LOCK-IT-100 study for Neutrolin® as a catheter lock solution in hemodialysis patients.
Catalyst: Unblinding of trail results,FDA approval, buyout/partnership
Cormedix Inc. Announces Highly Statistically Significant Topline Results For Neutrolin(R) From The Interim Analysis Of The Phase 3 Lock-It-100 Study - Press Release - Digital Journal
Brief:CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced the topline results of the interim analysis of the Company's Phase 3 LOCK-IT-100 study for Neutrolin® as a catheter lock solution in hemodialysis patients.
Catalyst: Unblinding of trail results,FDA approval, buyout/partnership
Cormedix Inc. Announces Highly Statistically Significant Topline Results For Neutrolin(R) From The Interim Analysis Of The Phase 3 Lock-It-100 Study - Press Release - Digital Journal
I got $64 left over sitting in my trade account and this is under $2. I'll buy some just on the off chance it takes off.
AMRN has the world's next blockbuster drug.
Buyout talks from Pfizer is really heating up.
Pfizer is rumoured to be on the brink of a deal to acquire small biopharma Amarin in the wake of stellar data for its purified fish oil product Vascepa in cardiovascular disease prevention.
A StreetInsider report suggests it is preparing to put a bid in for Amarin, hoping to tap into a sales boost for Vascepa (icosapent ethyl) based on the REDUCE-IT trial, which found that the drug cut the risk of heart attacks and stroke by 25% in high-risk cardiovascular patients.
Pfizer takeover rumour ignites Amarin shares
the latest rumor is a 3 to 1 share buyout offer.
Before, the rumor was a buyout of anywhere from $30B to $80B, which is between, $75 and $200+ per share. CUrrent price is $17.
I actually sold off most of my portfolio last year and put it in this. Watch it go from $9 to $23, then back down to $12. I was hurting, but I held on and added more and more when i could.
If the BO offer end up equaling over $150 a share, I will prolly retire within 3 months, or so after it happens.
Buyout talks from Pfizer is really heating up.
Pfizer is rumoured to be on the brink of a deal to acquire small biopharma Amarin in the wake of stellar data for its purified fish oil product Vascepa in cardiovascular disease prevention.
A StreetInsider report suggests it is preparing to put a bid in for Amarin, hoping to tap into a sales boost for Vascepa (icosapent ethyl) based on the REDUCE-IT trial, which found that the drug cut the risk of heart attacks and stroke by 25% in high-risk cardiovascular patients.
Pfizer takeover rumour ignites Amarin shares
the latest rumor is a 3 to 1 share buyout offer.
Before, the rumor was a buyout of anywhere from $30B to $80B, which is between, $75 and $200+ per share. CUrrent price is $17.
I actually sold off most of my portfolio last year and put it in this. Watch it go from $9 to $23, then back down to $12. I was hurting, but I held on and added more and more when i could.
If the BO offer end up equaling over $150 a share, I will prolly retire within 3 months, or so after it happens.
Another link from today:
Would Pfizer Shareholders Win With an Acquisition of Amarin? -- The Motley Fool
Would Pfizer Shareholders Win With an Acquisition of Amarin? -- The Motley Fool
It would have been great to know about this stock back in September that's when it was still in single digits under $3. Not to say it still cannot take off, as I've made and lost a lot in BIOtech stocks but it's at a high price right now
Just curious, what brokerage do you all use?
I use TD Ameritrade. A bit expensive for the basic stuff I use it for but excellent even for new and seasoned investors (their training is real good). $10 per trade (buy or sell).
There are others out there like Fidelity, and even cheaper ones. Shop around until you find the best one for you. I believe you can always cancel and transfer funds (or just withdraw your funds and close the account).
I use TD Ameritrade. A bit expensive for the basic stuff I use it for but excellent even for new and seasoned investors (their training is real good). $10 per trade (buy or sell).
There are others out there like Fidelity, and even cheaper ones. Shop around until you find the best one for you. I believe you can always cancel and transfer funds (or just withdraw your funds and close the account).
Fidelity but I also opened an account with Chase as that's my normal bank. They gave me 100 commission free trades so I'll take them up on that. It would be a lot cleaner to have all my stuff with one broker through. After I use those trades I'll probably transfer my assets to Fidelity.
How does the transfers work?
Are the shares transferred directly into the new account?
or do you have to sell off in one account, then transfer the funds into the new account, then re-buy?
When I transferred my AT&T shares from Computershare to Fidelity I just gave them an account number and a PDF statement and they handled the rest. Took a few days. There was no sell off it just moved to Fidelity.